PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis
author
statement of authorship
Vadim Lankin, Alla Tikhaze, Irina Chazova, Margus Viigimaa
location of publication
[Tallinn]
publisher
year of publication
pages
p. 38-39
conference name, date
7th Baltic Atherosclerosis Society Congress, April 6-7, 2018
conference location
Tallinn, Estonia
ISSN
0235-8026
TTÜ department
language
inglise
subject term
Lankin, V., Tikhaze, A., Chazova, I., Viigimaa, M. PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis // 7th Baltic Atherosclerosis Society Congress : [abstracts]. [Tallinn] : [Celsius Healthcare], 2018. p. 38-39. (Eesti Arst ; vol. 97, 2018 : lisa).